mortality/aging
|
• average survival is 8.5 +/- 2.3 months
|
neoplasm
|
• initiation and progression of acinar-ductal metaplasia and pancreatic intraepithelial neoplasia (PanIN) lesions are slower than in Krastm4Tyj/Kras+ Trp53tm1Brn/Trp53+ Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ (KPCY) mice
• mice show lower pancreatic ductal adenocarcinoma and metastasis incidence than in KPCY mice
|
|
• mice show lower lung and liver metastasis from pancreatic ductal adenocarcinoma than in KPCY mice
|
endocrine/exocrine glands
|
• initiation and progression of acinar-ductal metaplasia and pancreatic intraepithelial neoplasia (PanIN) lesions are slower than in Krastm4Tyj/Kras+ Trp53tm1Brn/Trp53+ Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ (KPCY) mice
• mice show lower pancreatic ductal adenocarcinoma and metastasis incidence than in KPCY mice
|


Analysis Tools